← Back to Search

Lay Navigator Intervention for End of Life (CAREPlan Trial)

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after patient enrollment
Awards & highlights

CAREPlan Trial Summary

This trial is testing if a layperson can help cancer patients with advance care planning, to improve patient activation, satisfaction, quality of life, and the quality of end of life cancer care.

Eligible Conditions
  • End of Life
  • Cancer

CAREPlan Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after patient enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months after patient enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Goals of Care Documentation
Secondary outcome measures
Emergency Department Visit using chart abstraction
Hospice using chart abstraction
Hospitalization Visit using chart abstraction
+1 more

CAREPlan Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group ArmExperimental Treatment2 Interventions
Patients randomized into the intervention will be assigned a lay patient navigator who will provide information regarding early advance care planning, documentation of goals of care, and coordinating home-based care. The intervention arm will also receive usual care as provided by their local oncologists.
Group II: Control Group ArmActive Control1 Intervention
The control group will receive usual care as provided by their local oncologists.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lay Navigator Intervention
2019
N/A
~400

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,408 Previous Clinical Trials
17,342,807 Total Patients Enrolled
5 Trials studying End of Life
4,601 Patients Enrolled for End of Life

Media Library

Lay Navigator Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03856463 — N/A
End of Life Research Study Groups: Control Group Arm, Intervention Group Arm
End of Life Clinical Trial 2023: Lay Navigator Intervention Highlights & Side Effects. Trial Name: NCT03856463 — N/A
Lay Navigator Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03856463 — N/A
~65 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top